Tackling Multiple Sclerosis

Thanks to the Barford and Love families, St. Michael’s BARLO MS Centre will change the face of multiple sclerosis everywhere.

Canada holds the dubious distinction of having the highest rate of MS in the world – approximately 100,000 Canadians live with the disease. Every eight hours, another person is diagnosed.

Here’s the good news. Toronto will soon be home to a world-leading MS centre that is on track to stopping this intractable disease. That’s in large part thanks to a transformational $20 million contribution from the Barford and Love families.

We’re perfectly positioned to capitalize on this remarkable gift. St. Michael’s already has some of the most preeminent neurologists in the country. We’ve long been a global powerhouse in MS research. And we’ve recruited Dr. Xavier Montalban, one of the most prominent MS neurologists in the world.

The BARLO MS Centre will integrate basic research, translational research and clinical care all in one place. That means we’ll be able to identify new drugs and figure out how to use old drugs in new ways. We’ll test drugs in labs and then in fish – St. Michael’s has one of the most advanced zebrafish facilities in the world – and finally in clinical trials.

And the care will be unique. Patients won’t just get a doctor. They’ll get a team of doctors, nurses, a social worker, an occupational therapist, a physical therapist, a speech therapist and a neuropsychologist, all in one place. Because MS isn’t just a disease that affects people’s bodies. It tears apart marriages. It puts people out of jobs. It disrupts parenting. It impacts families. The stress of the disease can be as debilitating as the disease itself.

For the first time, we have the chance to catapult advances in MS to a whole new sphere of progress. Join the Barfords and the Loves in bringing the BARLO MS Centre to life.